Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Newmont Mining: A Clash of Titans as Gold Prices Soar

Robert Sasse by Robert Sasse
November 24, 2025
in Analysis, Commodities, Gold & Precious Metals
0
Newmont Mining Stock
0
SHARES
75
VIEWS
Share on FacebookShare on Twitter

While gold futures trade firmly above $4,100 per ounce, propelled by central bank acquisitions and geopolitical uncertainty, a significant divergence of opinion is unfolding among major stakeholders of the world’s largest gold producer, Newmont Mining. The recent trading activity reveals a dramatic split in institutional sentiment, creating a battleground for the stock’s future direction.

Institutional Giants Take Opposing Bets

A striking divergence has emerged on Wall Street regarding Newmont’s valuation. On one side, Franklin Resources executed a substantial retreat, slashing its stake by approximately 34.7 percent, a move that involved divesting more than 1.3 million shares. Such a significant sell-off by a heavyweight investor inevitably draws market attention.

However, this bearish stance is far from universal. Contradicting this view, Prudential Financial aggressively increased its holding by a solid 58.0 percent during the same period. The most bullish bet came from Summit Global Investments, which nearly tripled its position with a staggering 189.5 percent increase. This extreme polarization highlights the heated debates occurring in investment divisions over the company’s valuation, a controversy fueled by the stock’s powerful rally since the start of the year.

The opposing camps are clearly defined:
* Prudential Financial: Significantly increases stake (+58.0%)
* Summit Global Investments: Places aggressive bullish wager (+189.5%)
* Franklin Resources: Executes major reduction (-34.7%)

Should investors sell immediately? Or is it worth buying Newmont Mining?

Record Gold Prices Meet Operational Execution

The context for this high-stakes drama is a gold market trading at historic highs, an environment that should, in theory, be highly favorable for a mining giant like Newmont. Yet, investors are now scrutinizing the company’s operational follow-through, particularly in the wake of its acquisition of Newcrest.

The market’s focus has shifted to Newmont’s strategy for strengthening its balance sheet. The company has outlined plans to generate around $3 billion in cash through the divestment of certain assets. While the corporation maintains a robust financial position with total liquidity of $9.6 billion, the key question for investors is how effectively this capital will be deployed to create shareholder value.

Leadership Transactions Stir the Pot

Adding another layer of complexity are transactions from within the company’s own leadership. Both CEO Thomas Ronald Palmer and Director Bruce R. Brook sold portions of their shareholdings in November. Although these sales represent only a small fraction of their total holdings, the decision by insiders to cash out during a record-breaking rally sends a mixed signal to the market. It inevitably prompts investors to question the rationale behind the sales when the external environment appears so ideal.

With its share price currently at €73.84 and having climbed over 97 percent since the beginning of the year, Newmont stands at a critical juncture. The massive repositioning by these institutional “big boys” suggests that the straightforward upward climb may be over. The battle for control over the narrative surrounding Newmont’s future cash flows has now decidedly begun.

Ad

Newmont Mining Stock: Buy or Sell?! New Newmont Mining Analysis from March 25 delivers the answer:

The latest Newmont Mining figures speak for themselves: Urgent action needed for Newmont Mining investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Newmont Mining: Buy or sell? Read more here...

Tags: Newmont Mining
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Watsco Stock
Analysis

Watsco’s Dividend Hike Contrasts with Operational Headwinds

March 25, 2026
Oracle Stock
AI & Quantum Computing

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

March 25, 2026
Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Next Post
Altria Stock

Major Investors Exit Altria Despite Compelling Valuation

Tilray Stock

Tilray Gains Strategic Foothold in Québec's Newly Legalized Vape Market

Kraft Heinz Stock

Kraft Heinz: Dividend Allure Masks Deeper Troubles

Recommended

K+S Stock

U.S. Sanctions Relief for Belarus Sends K+S Shares Tumbling

4 days ago
Finance_ Charts for stock trading

AMark Precious Metals Inc to Acquire Prominent Asian Precious Metals Dealer LPM Group Limited

2 years ago
European Lithium Stock

European Lithium Shares Reflect Divergent Investor Sentiment

3 months ago
RLI stock news

Chicago Partners Investment Group LLC’s Surprising Reduction in Stake Raises Questions for Qurate Retail

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

Ocugen Shares Tumble Despite Positive Clinical Trial Results

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Trending

Lexaria Bioscience Stock
Healthcare

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

by Rodolfo Hanigan
March 25, 2026
0

Lexaria Bioscience is positioning its proprietary DehydraTECH technology as a potential solution to a critical problem plaguing...

Watsco Stock

Watsco’s Dividend Hike Contrasts with Operational Headwinds

March 25, 2026
Pinduoduo Stock

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

March 25, 2026
XPeng Stock

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

March 25, 2026
Oracle Stock

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution
  • Watsco’s Dividend Hike Contrasts with Operational Headwinds
  • Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com